Founded in the 1980s, Biopharm Australia is committed to furthering animal health through the best technology. Biopharm has been a world leader in osteoarthritis treatments for over 20 years. In order to achieve our aim of improving health through improved technology, Biopharm heavily invests in the development of new technologies and medicines that improve the quality of life of animals and strengthens the human-animal bond through good medicine.
Safety has always been at the forefront of our products, particularly with complex and large molecules such as polysaccharides. Of course, efficacy is the cornerstone of our products with clinical studies being carried out in Australia, Canada, Denmark, Finland, Germany, Japan, New Zealand, the United Kingdom and USA. Scientific collaboration has been carried out with numerous local and overseas institutions.
Our high standards of safety and efficacy are acknowledged by our products being accepted as veterinary medicines by regulatory authorities around the world. Our products have been widely used, from beloved companion animals in homes to multi-million dollar horses at race tracks and we continue to ensure that our products are always produced to deliver the highest levels of efficacy and safety. The sodium pentosan polysulfate used in Biopharm’s arthritis medicines is the same material approved and used in Europe in humans for non-arthritis conditions for more than 50 years.
The quality of Biopharm products is strengthened by the excellence of its quality assurance testing laboratories that are accredited by the National Association of Testing Authorities, Australia (NATA) and licensed by the Therapeutic Goods Administration (TGA). These accreditations are recognised globally under mutual recognition agreements in each region.
You can rest at ease with Biopharm products, knowing that they are of the highest quality and reliability.